SCHEMBL4083578

SCHEMBL4083578

Cc1ccc2c(c1)c(C(=O)C(=O)N(Cc1ccc(Cl)cc1)c1ccccc1)c(C)n2Cc1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.55
PLA2G2A P14555 1/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
HTT P42858 2/20 0.45
MAPT P10636 3/20 0.44
PKM P14618 3/20 0.44
GAA P10253 2/20 0.44
ALDH1A1 P00352 2/20 0.44
LMNA P02545 4/20 0.44
PTGES O14684 2/20 0.44
ALOX5 P09917 2/20 0.44
KDM4E B2RXH2 1/20 0.43
PTGDR2 Q9Y5Y4 3/20 0.42
AKR1B1 P15121 1/20 0.42
CYP2C9 P11712 2/20 0.42
RGS12 O14924 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083770 0.85 L3MBTL1 (0.45) FAAHPLA2G2AKMT2AMAPTPKM
SCHEMBL2169467 0.81 FAAH (0.70) FAAHPLA2G2AKMT2AMEN1HTT
SCHEMBL2998356 0.77 PLA2G2A (0.64) PLA2G2AKMT2AMEN1HTTMAPT
SCHEMBL2169902 0.75 FAAH (0.71) FAAHKMT2AMEN1HTTMAPT
SCHEMBL2169486 0.73 FAAH (0.77) FAAHKMT2AMEN1HTTMAPT
SCHEMBL3011391 0.73 FAAH (0.58) FAAHPLA2G2AKMT2AMEN1HTT
SCHEMBL3008672 0.73 FAAH (0.60) FAAHKMT2AMEN1HTTMAPT
SCHEMBL2992971 0.72 FAAH (0.57) FAAHKMT2AMEN1HTTMAPT
SCHEMBL2170093 0.72 FAAH (0.69) FAAHKMT2AMEN1HTT
SCHEMBL2570582 0.72 FAAH (0.43) FAAHKMT2AMEN1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885PLA2G2A 242/4885KMT2A 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.